Andere Sprachen Zealand Pharma A/S

Aktien

A0YJW7

DK0060257814

ZEAL

Biotechnologie

Markt geschlossen - Nasdaq Copenhagen Andere Börsenplätze 17:20:00 14.02.2025			% 5 Tage	% 1. Jan.
753,00 ^DKK	+0,60 %		+3,36 %	+5,24 %

29.01.	SEB stuft Zealand Pharma auf Halten (Kaufen) zurück, Kursziel DKK 800 - BN	FW
24.01.	Novo Nordisk steigt nach positiven Ergebnissen für Amycretin - 22 Prozent Gewichtsverlust (Update)	FW

Andere Sprachen

Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results	13.02.
La Fed et Microsoft pour oublier DeepSeek ?	29.01.
Avis d'analystes du jour : LVMH, EssilorLuxottica, Sartorius Stedim Biotech, Airbus, Eiffage, Logitech, Nestlé…	29.01.
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	13.01.
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity	07.01.
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity	07.01.
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th	06.01.
Transactions in Zealand Pharma shares and or related securities by persons discharging managerial responsibilities and or their closely associated persons	27.12.
Zealand Pharma major shareholder announcement, The Capital Group Companies, Inc	27.12.
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	25.12.
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	25.12.
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.	25.12.
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.	25.12.
Zealand Pharma A/S(CPSE:ZEAL) added to OMX Nordic 40 Index	23.12.
Zealand Pharma A/S - U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome	20.12.
Les actions en mouvement : Novo Nordisk bien sur mais aussi Idorsia qui s'effondre	20.12.
Borse Europa in calo, investitori preoccupati su avvertimento Trump a Ue	20.12.
Zealand Pharma Shares Fall After FDA Pushes Back Bowel-Disease Drug	20.12.
Faucons, vrais doutes	20.12.
En direct des marchés : Vinci, Diageo, Crédit Agricole, Fedex, Rio Tinto, Orange, Réalités, Nike…	20.12.
Correction: Zealand Pharma Gets US FDA's Complete Response Letter for Short Bowel Syndrome Drug	20.12.
Zeland Pharma Gets US FDA's Complete Response Letter for Short Bowel Syndrome Drug	20.12.
Zealand Pharma Fails to Get FDA Approval for Short Bowel Syndrome Drug	19.12.
Zealand Pharma Falls Short of FDA Approval for Glepaglutide	19.12.
U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome	19.12.

Werden Sie Mitglied, um Zugang zu mehr Nachrichten zu erhalten.

100% kostenlose Registrierung

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Zealand Pharma A/S

Aktien

A0YJW7

DK0060257814

ZEAL

Biotechnologie

Andere Sprachen

Filter